Caplin Point Laboratories Limited
NSE: CAPLIPOINTINE475E01026·HealthcareSmallcap 250·www.caplinpoint.net ↗·Mcap ₹21,217 Cr·Listed 2014
₹2,835.10▼ ₹32.30  (−1.13%)
52W: ₹1,500 – ₹2,990 · Vol: 1.8L shares · Close 25 Sept
Set Alert
OverviewFinancialsChartsWavesScreenersThesisNewsPeers

News & Filings

NSE filings · newest first · 4 on record

Fri, 25 Sept, 2026

Copy Srutinizers report of Annual General Meeting held on September 25, 2026. Further, the company has informed the Exchange regarding voting results.
Voting resultShareholders meeting19:15 IST PDF 1.25 MB XBRL
Proceedings of Annual General Meeting held on September 25, 2026
AGM / EGMShareholders meeting15:37 IST PDF 347.52 KB XBRL

Thu, 24 Sept, 2026

Significant increase in volume has been observed in Caplin Point Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Caplin Point Laboratories Limited has submitted their response.
Exchange clarificationSpurt in Volume18:45 IST PDF 0 Bytes XBRL
Significant increase in volume has been observed in Caplin Point Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.
Exchange clarificationSpurt in Volume17:41 IST XBRL
Source: NSE corporate announcements, as filed by the company. Times are IST. Press coverage is not included yet.
Filing activity · 30 days
4filings · +4 vs the 30 days before
● Board & AGM 2● Regulatory 2
NSE filings by type. Press coverage and sentiment are not included yet.
Material vs routine · 90 days
Material events 2 in 90 days
24 SeptExchange clarification Significant increase in volume has been observed in Caplin Point Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Caplin Point Laboratories Limited has submitted their response. PDF
24 SeptExchange clarification Significant increase in volume has been observed in Caplin Point Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.
Routine disclosures 2
board & agm 2
Split by NSE filing category: business events (results, ratings, deals, leadership, capital actions, regulatory) versus schedules, notices and general updates. Not a view on importance.
Corporate Actions
loading…